These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 29510666

  • 1. Factors affecting time to sputum culture conversion and treatment outcome of patients with multidrug-resistant tuberculosis in China.
    Liu Q, Lu P, Martinez L, Yang H, Lu W, Ding X, Zhu L.
    BMC Infect Dis; 2018 Mar 06; 18(1):114. PubMed ID: 29510666
    [Abstract] [Full Text] [Related]

  • 2. Time to sputum smear and culture conversions in multidrug resistant tuberculosis at University of Gondar Hospital, Northwest Ethiopia.
    Shibabaw A, Gelaw B, Wang SH, Tessema B.
    PLoS One; 2018 Mar 06; 13(6):e0198080. PubMed ID: 29944658
    [Abstract] [Full Text] [Related]

  • 3. Body mass index predictive of sputum culture conversion among MDR-TB patients in Indonesia.
    Putri FA, Burhan E, Nawas A, Soepandi PZ, Sutoyo DK, Agustin H, Isbaniah F, Dowdy DW.
    Int J Tuberc Lung Dis; 2014 May 06; 18(5):564-70. PubMed ID: 24903794
    [Abstract] [Full Text] [Related]

  • 4. Predictors of sputum culture conversion among patients treated for multidrug-resistant tuberculosis.
    Kurbatova EV, Gammino VM, Bayona J, Becerra MC, Danilovitz M, Falzon D, Gelmanova I, Keshavjee S, Leimane V, Mitnick CD, Quelapio MI, Riekstina V, Taylor A, Viiklepp P, Zignol M, Cegielski JP.
    Int J Tuberc Lung Dis; 2012 Oct 06; 16(10):1335-43. PubMed ID: 23107633
    [Abstract] [Full Text] [Related]

  • 5. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
    Magee MJ, Kempker RR, Kipiani M, Tukvadze N, Howards PP, Narayan KM, Blumberg HM.
    PLoS One; 2014 Oct 06; 9(4):e94890. PubMed ID: 24736471
    [Abstract] [Full Text] [Related]

  • 6. Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
    Yuen CM, Kurbatova EV, Tupasi T, Caoili JC, Van Der Walt M, Kvasnovsky C, Yagui M, Bayona J, Contreras C, Leimane V, Ershova J, Via LE, Kim H, Akksilp S, Kazennyy BY, Volchenkov GV, Jou R, Kliiman K, Demikhova OV, Vasilyeva IA, Dalton T, Cegielski JP.
    PLoS Med; 2015 Dec 06; 12(12):e1001932. PubMed ID: 26714320
    [Abstract] [Full Text] [Related]

  • 7. Time to sputum culture conversion in multidrug-resistant tuberculosis: predictors and relationship to treatment outcome.
    Holtz TH, Sternberg M, Kammerer S, Laserson KF, Riekstina V, Zarovska E, Skripconoka V, Wells CD, Leimane V.
    Ann Intern Med; 2006 May 02; 144(9):650-9. PubMed ID: 16670134
    [Abstract] [Full Text] [Related]

  • 8. Unacceptable treatment outcomes and associated factors among India's initial cohorts of multidrug-resistant tuberculosis (MDR-TB) patients under the revised national TB control programme (2007-2011): Evidence leading to policy enhancement.
    Parmar MM, Sachdeva KS, Dewan PK, Rade K, Nair SA, Pant R, Khaparde SD.
    PLoS One; 2018 May 02; 13(4):e0193903. PubMed ID: 29641576
    [Abstract] [Full Text] [Related]

  • 9. Comparison of the validity of smear and culture conversion as a prognostic marker of treatment outcome in patients with multidrug-resistant tuberculosis.
    Alene KA, Viney K, Yi H, McBryde ES, Yang K, Bai L, Gray DJ, Xu Z, Clements ACA.
    PLoS One; 2018 May 02; 13(5):e0197880. PubMed ID: 29791488
    [Abstract] [Full Text] [Related]

  • 10. Predictors of early and interim culture un-conversion in multidrug-resistant/rifampicin-resistant tuberculosis: a retrospective multi-center cohort study in China.
    Chen Q, He W, Du J, Kang W, Zou L, Tang X, Tang P, Guo C, Pan Q, Zhu Q, Yang S, Guo Z, Wu G, Tang S.
    Antimicrob Resist Infect Control; 2024 Oct 15; 13(1):126. PubMed ID: 39407338
    [Abstract] [Full Text] [Related]

  • 11. Cigarette smoking and culture conversion in patients with susceptible and M/XDR-TB.
    Reimann M, Schaub D, Kalsdorf B, Runge C, Carballo PS, Terhalle E, Salzer HJF, Lange C, Heyckendorf J.
    Int J Tuberc Lung Dis; 2019 Jan 01; 23(1):93-98. PubMed ID: 30674380
    [Abstract] [Full Text] [Related]

  • 12. Comparison of bacteriological conversion and treatment outcomes among MDR-TB patients with and without diabetes in Mexico: Preliminary data.
    Muñoz-Torrico M, Caminero Luna J, Migliori GB, D'Ambrosio L, Carrillo-Alduenda JL, Villareal-Velarde H, Torres-Cruz A, Flores-Ergara H, Martínez-Mendoza D, García-Sancho C, Centis R, Salazar-Lezama MÁ, Pérez-Padilla R.
    Rev Port Pneumol (2006); 2017 Jan 01; 23(1):27-30. PubMed ID: 28043788
    [Abstract] [Full Text] [Related]

  • 13. Determinants of sputum culture conversion time in multidrug-resistant tuberculosis patients in ALERT comprehensive specialized hospital, Addis Ababa, Ethiopia: A retrospective cohort study.
    Abebe M, Atnafu A, Tilahun M, Sero N, Neway S, Alemu M, Tesfaye G, Mihret A, Bobosha K, Wan C.
    PLoS One; 2024 Jan 01; 19(5):e0304507. PubMed ID: 38820260
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. pncA mutations are associated with slower sputum conversion during standard treatment of multidrug-resistant tuberculosis.
    Zheng X, Ning Z, Drobniewski F, Yang J, Li Q, Zhang Z, Hu Y.
    Int J Antimicrob Agents; 2017 Feb 01; 49(2):183-188. PubMed ID: 28012685
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K, Viiklepp P, Guðmundsson LJ, Altraja A.
    Int J Tuberc Lung Dis; 2012 Sep 01; 16(9):1228-33. PubMed ID: 22748131
    [Abstract] [Full Text] [Related]

  • 19. Time to sputum culture conversion and its predictors among patients with multidrug-resistant tuberculosis in Hangzhou, China: A retrospective cohort study.
    Li Q, Lu M, Hsieh E, Wu L, Wu Y, Wang M, Wang L, Zhao G, Xie L, Qian HZ.
    Medicine (Baltimore); 2020 Dec 11; 99(50):e23649. PubMed ID: 33327347
    [Abstract] [Full Text] [Related]

  • 20. Predictors and mortality associated with treatment default in pulmonary tuberculosis.
    Kliiman K, Altraja A.
    Int J Tuberc Lung Dis; 2010 Apr 11; 14(4):454-63. PubMed ID: 20202304
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.